Management of Guillain-Barré Syndrome
Initial Assessment and Management
- The American Academy of Neurology recommends admitting patients with suspected Guillain-Barré Syndrome to an inpatient unit with capability for rapid transfer to ICU-level monitoring, as GBS can rapidly progress to respiratory failure 3
- Perform neurological consultation immediately to confirm diagnosis and guide treatment, as recommended by the American Academy of Neurology 3, 1
- Conduct respiratory function assessment using vital capacity, maximum inspiratory pressure, maximum expiratory pressure, single breath count, and assessment of accessory respiratory muscle usage, as suggested by the European Academy of Neurology 4, 1
Diagnostic Workup
- The American Academy of Neurology recommends performing MRI spine with and without contrast to rule out compressive lesions 3
- Conduct lumbar puncture for CSF analysis, which typically shows elevated protein, as recommended by the American Academy of Neurology 3
- Order electrodiagnostic studies, such as NCS and EMG, to evaluate polyneuropathy, as suggested by the American Association of Neuromuscular and Electrodiagnostic Medicine 3, 1
Treatment Plan
- The American Academy of Neurology recommends starting IVIg at 0.4 g/kg/day for 5 consecutive days, with a total dose of 2 g/kg, as a first-line treatment for GBS 1, 2
- The 5-day regimen is preferred over shorter regimens, as treatment-related fluctuations are more frequent with shorter regimens, according to the American Academy of Neurology 2
Monitoring During Treatment
- Perform frequent neurological assessments to track disease progression, as recommended by the European Academy of Neurology 4, 1
- Monitor autonomic dysfunction via electrocardiography, heart rate, blood pressure, and bowel/bladder function, as suggested by the American Autonomic Society 4, 2